Dynatronics Corporation announces that it has received approval to market its SolarisPlus Series in Singapore and Peru.
The company received this approval from the health Sciences Authority of Singapore and the Ministry of Health of Peru, and will market the SolarisPlus Series of therapy products to physical therapy and sports medicine clinicians during the first quarter of calendar 2016, explains a media release from Dynatronics.
“Building international revenue is a cornerstone of our growth strategy, and these two approvals illustrate continued successful execution by our team,” says Kelvyn H. Cullimore, Jr, chairman & CEO of Dynatronics, in the release.
The SolarisPlus Series consists of four separate units that are capable of providing seven waveforms of electrotherapy along with Dynatronics’ proprietary three-frequency ultrasound therapy, phototherapy, and thermal therapy, the release explains.
For more information, visit Dynatronics.
[Source(s): Dynatronics Corp, PR Newswire]